AstraZeneca has returned to the coronavirus vaccine testing process. This work is being done in tandem with the staff of Oxford University.
Image via: pixabay.com
We are talking about the AZD1222 vaccine, the trials of which had to be suspended amid strange health problems in one of the volunteers. Subsequently, the regulator in the UK, represented by the MHRA, gave the green light to continue working. Although the details of the volunteer's illness remain unknown, experts call the continuation of the tests safe. The decision to suspend it was made on September 6, and all over the world. This was due to the need to organize an independent study to understand whether the volunteer's condition is directly related to the drug.
Until the end of 2020, AstraZeneca will know for sure whether the developed vaccine really protects against COVID-19.